Back

Chronic vagal nerve stimulation suppress thirst through decreasing vasopressin secretion in the rats with chronic heart failure

9 November 2019 (09:00 - 13:00)
Organised by:
Congress Presentation Part of: Poster Session Saturday 1 Devices for Autonomic Modulation ESC Premium Access ESC Asia with APSC & AFC

About the speaker

Photo
Doctor Can Zheng

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

31 More presentations in this session

Presentation thumbnail
Role of inflammation as a risk factor for atrial fibrillation in rheumatic mitral stenosis and its correlation with atrial late gadolinium enhancement (LGE) on cardiac MRI
Associate Professor M. Malik (Aligarh, IN)
Abstract Slides
Presentation thumbnail
Evaluation of enhances 5-aminolevulinic acid-mediated photodynamic therapy effect on endothelial function in a hamster carotid artery ballooning injury model using a new computerized ultrasound image
Doctor H. Mehrad (Tabriz, IR)
Presentation thumbnail
Prognostic value of tissue-tracking mitral annular displacement by speckle-tracking echocardiography in asymptomatic patients with aortic stenosis with preserved left ventricular ejection fraction
Doctor I. Teraguchi (Wakayama, JP)
Abstract
Presentation thumbnail
A novel method of correcting the left ventricular stroke volume by Doppler echocardiography: comparison with multidetector computed tomography
Miss C. Toriyama (Osaka, JP)
Abstract Slides
Presentation thumbnail
The usefulness of dual cardiac autonomic nervous modulation assessment for prediction of mortality in patients with relatively preserved left ventricular ejection fraction
Assistant Professor T. Kinoshita (Tokyo, JP)
Abstract

Access the full session

Session thumbnail
Poster Session Saturday 1

The Event

Event poster

ESC Asia with APSC & AFC

9 November 2019 09:00 CET
You may be interested in
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
When to consider device therapy in HFrEF
thumbnail
Congress Session
Navigating through heart failure device therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources